July 11, 2017 09:17 AM EDT

Neothetics sheds staff, looks for survival strategy in wake of trial failure; GSK walks away from OncoMed pact

Shehla Shakoor

Managing Director

⇨ About two weeks after Neothetics’ shares $NEOT nose-dived into penny stock territory following the Phase II failure of its aesthetic fat-buster, the company says …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Neothetics sheds staff, looks for survival strategy in wake of trial failure; GSK walks away from OncoMed pact

Shehla Shakoor

Managing Director

Sign up to read this article for free.

Revolution Medicines' KRAS drug shows potential in early cut of lung cancer data

Exclusive: Can AI replace animal testing? A new biotech launches to find out

France stops Valneva's chikungunya vaccine rollout in over 65s after safety issue

GSK’s checkpoint blocker Jemperli cures biomarker-driven rectal cancer

European regulators recommend new drugs from Vertex, Amgen and Jazz

Revolutionizing obesity treatment: Could mitochondria hold the key to unlocking fat-specific weight loss?

Neo­thet­ics sheds staff, looks for sur­vival strat­e­gy in wake of tri­al fail­ure; GSK walks away from On­coMed pact

Shehla Shakoor

Managing Director

Sign up to read this article for free.

Rev­o­lu­tion Med­i­ci­nes' KRAS drug shows po­ten­tial in ear­ly cut of lung can­cer da­ta

Ex­clu­sive: Can AI re­place an­i­mal test­ing? A new biotech launch­es to find out

France stops Val­neva's chikun­gun­ya vac­cine roll­out in over 65s af­ter safe­ty is­sue

GSK’s check­point block­er Jem­per­li cures bio­mark­er-dri­ven rec­tal can­cer

Eu­ro­pean reg­u­la­tors rec­om­mend new drugs from Ver­tex, Am­gen and Jazz

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

Neothetics sheds staff, looks for survival strategy in wake of trial failure; GSK walks away from OncoMed pact

Revolution Medicines' KRAS drug shows potential in early cut of lung cancer data

Exclusive: Can AI replace animal testing? A new biotech launches to find out

France stops Valneva's chikungunya vaccine rollout in over 65s after safety issue

GSK’s checkpoint blocker Jemperli cures biomarker-driven rectal cancer

European regulators recommend new drugs from Vertex, Amgen and Jazz

Revolutionizing obesity treatment: Could mitochondria hold the key to unlocking fat-specific weight loss?